Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 26 for “"FXIIIa"”.
-
The roles of fibrinolysis in regulating coagulation factor XIII
… end of the coagulation cascade. Activated FXIII (FXIIIa) stabilizes the blood clot from premature lysis by covalently crosslinking fibrin molecules to itself and to other anti-fibrinolytic proteins. Although the role of FXIIIa as an antifibrinolytic protein has been well characterized, the role of …
-
Coagulation Factor XIIIA: biochemical properties underlying physiological function.
Factor XIIIA (FXIIIA) is a transglutaminase that crosslinks intra- and extracellular protein substrates. The oligomeric state of active FXIIIA remains controversial, and the present work commenced with addressing this issue. The results of size exclusion chromatography and analytical …
-
Coagulation Factor XIIIA: Clinical and Biological Significance in Epithelial Ovarian Cancer
… of its A-subunit, selected F13A1 genotypes, FXIIIA protein expression in tumour tissues, and plasma levels of stable FDP as determined by D-Dimer levels were concurrently explored for the first time in EOC (patients entered into the translational cohort of the ICON7 trial, n=91). The …
-
Synthesis and Evaluation of Peptidic Probes for Tissue Transglutaminase and Factor XIIIa
… tissue transglutaminase (TG2) and Factor XIIIa (FXIIIa) have been found to play in a wide range of disease states, efforts have been directed towards the study of these proteins. The study of enzymes to better understand their function and mode of action is facilitated through the use of tools …
-
Factor XIIIA Genotypes to Outcome in Epithelial Ovarian Cancer
… makes treatment challenging. Factor XIIIA (FXIIIA) is a transglutaminase which crosslinks fibrin to form stable blood clots, as well as having other roles in inflammation and angiogenesis. FXIIIA plasma levels, activity and protein expression have been linked to cancer, including a brief …
-
Local and systemic delivery of a novel group of inhibitors of transglutaminase enzyme:a potential approach for treating of catheter-related complications and liver fibrosis
… labelled inhibitors of Factor XIIIa (FXIIIa). These small, non-toxic inhibitors have the potential to prevent stabilisation of thrombi by FXIIIa and consequently increase the natural rate of thrombolysis, in addition it reduces staphylococcal colonisation of catheters by inhibiting …
-
Evaluating transglutaminase crosslinked collagen gel systems for hard and soft tissue repair
Tissue Transglutaminase (TG2) and FXIIIa, members of the transglutaminase (TG) family, catalyses a transamidating reaction and form covalent bond between or within proteins. In bone development, both enzymes expressions correlate with the initial of the mineralisation process by osteoblasts and …
-
Modulating the adhesive strength of blood clots by coagulation factor XIIIa-based technologies
… found in wound tissues. We found that fibrin and FXIIIa increased clot adhesive strength in a concentration-dependent manner. Using this knowledge, we designed a formulation containing Q-PEG, a FXIIIa-crosslinkable synthetic macromer. The gelation of Q-PEG was coupled to the coagulation network …
-
Ανοσοϊστοχημική και παθογενετική μελέτη υμενίτιδων σε χειρουργικό και πειραματικό υλικό
… to CD68, galectin-3, indoleamin, MyD88, MUM-1, FXIIIa, egfr, hif1A and NF-kappaB were applied to 3μ sections from these FFPE samples. Immunoreactivity patterns were analyzed and an overall immunoprofile of these macrophages, was made. This immunoprofile consisted of: CD68(+), galectin-3(+), …
-
Platelet factor XIII contributes to the hemostatic process : factor XIII interactions at the platelet surface and with the internal platelet skeleton
… antibodies and flow cytometry indicate that FXIIIa association with platelets, occurred at early stages of activation, was partially reversible, correlated significantly with fibrinogen expression, and was enhanced after alkylation of the active-site cysteine. Immunoblotting experiments …
-
Site-specific biomolecule modification for directed surface attachment
… donor substrate in the crosslinking mechanism of FXIIIa. Additionally, the peptide was provided with a cysteine moiety to allow for highly flexible and simple loading of desired cargo molecules via conventional thiol-Michael addition, thus establishing an adaptive labeling platform. The effective …
-
Perturbations in protein dynamics associated with ligand binding to the blood coagulation enzymes thrombin and Factor XIII.
… of FXIII using MALDI-TOF MS. A peptide-based FXIIIa inhibitor has been developed with the glutamine isostere 6-diazo-5-oxo-norleucine (DON). The K9 DON peptide blocks chemical modification of C 409 within the catalytic core and promotes significant HDX protection for the ß barrel 1 fragment …
-
Smartphones for control and detection of rapid diagnostic tests
… blood clot, like fibrin cross-linking activator FXIIIa, can be functionally detected as resonance frequency shifts from the decreased total capacitance. Since flow control and analyte detection – two core components of a rapid diagnostic test – occurs in the audio frequency range, this …
-
Site directed molecular design and performances of Interferon-α2a and Interleukin-4 bioconjugates with PEG alternative polymers
… this, the transglutaminase (TG) Factor XIIIa (FXIIIa), which is an important human enzyme during blood coagulation can be used. FXIIIa can recognize specific peptide sequences that contain a lysine as substrates and link them covalently to another peptide sequence, that contains a glutamine, …
-
Design, Synthesis and Evaluation of Covalent Inhibitors for Tissue Transglutaminase and Factor XIIIa
… transglutaminase (hTG2) and human factor XIIIa (FXIIIa). Divided into two projects for each enzyme, the main objective of this thesis was directed towards the discovery of potent and selective covalent inhibitors for each isozyme, namely hTG2 and hFXIIIa. The first project was concentrated on the …
-
Laboratory assessment of factor XIII : impact of aspartic proteases and other influences on clot lysis and activity methods
… monomers and polymers and activates FXIII. FXIIIa stabilises fibrinogen polymers by catalysing the introduction of covalent bonds between adjacent fibrinogen α- and γ-chains. It also cross-links α2-antiplasmin into fibrin as a mechanism to reduce fibrinolysis. Later, after bleeding has …
-
A Mouse Model of Deep Vein Thrombosis Stability: The Effect of Direct Thrombin Inhibition
… through disruption of platelet, fibrin, and FXIIIa stabilizing mechanisms. This could manifest as increased thrombus embolization. A clinically relevant mouse model of DVT stability could further our understanding of venous thrombosis pathophysiology and define the effect of direct thrombin …
-
Monitoring enzyme activity by using mass-encoded peptides and multiplexed detection
… blood coagulation transglutaminase factor XIII (FXIIIa). The lysine of mass reporter’s TG sequence (D-domain of insulin-like growth factor-I (IGF-I)) and a glutamine in fibronectin are covalently crosslinked by FXIIIa and build an isopeptide bond. Elevated levels of MMP release the mass reporters …
-
Novel mediators of platelet-mediated hemostasis
… cleaves and degrades the active enzyme, FXIIIa, but not the zymogen, FXIII.
-
A MICROFLUIDIC APPROACH FOR INVEDSTIGATING THROMBOSIS AND HEMOSTASIS
… and concomitant peptide labeling of fibrin. The FXIIIa inhibitor T101 had no effect on fibrin generation but ablated the labeling of fibrin by the peptide. Similarly, Gly-Pro-Arg-Pro abated fibrin formation and thus strongly attenuated the peptide signal. At arterial wall shear rate, less fibrin …
Page 1 of 2